Eidos Therapeutics
Founded in 2017 and based in San Francisco, California, Eidos Therapeutics strives to develop biopharmaceutical solutions to diseases caused by transthyretin, or TTR, amyloidosis, or ATTR.
Last updated on
Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps
Learn More!Founded in 2017 and based in San Francisco, California, Eidos Therapeutics strives to develop biopharmaceutical solutions to diseases caused by transthyretin, or TTR, amyloidosis, or ATTR.